On 27 May 2026, during EASL Congress in Barcelona, the ARTEMIS project held its first layperson event, bringing together ELPA members, national patient representatives, researchers and healthcare professionals to discuss the future of virtual twins in healthcare.
The one-hour session combined presentations led by Prof. Irene Vignon-Clementel (Inria), a pioneer in Digital Human Twins, Dr. Raluca Pais (Pitié-Salpêtrière Hospital, Paris), and Prof. Juan Manuel Pericàs (Vall d’Hebron University Hospital). Moderated by ELPA President Marko Korenjak followed by an interactive Q&A, creating an open dialogue on how patient communities perceive digital twins and the role of trust in adopting innovative technologies in healthcare. Participants learned how the ARTEMIs project aims to accelerate the translation of virtual twins into personalised management for people living with steatotic liver disease (MASLD), while also sharing their expectations, concerns and questions regarding the use of such technologies in clinical practice.
The discussion highlighted the importance of involving people living with liver disease from the earliest stages of research and innovation. Trust, transparency, explainability and patient engagement emerged as key elements for the successful implementation of virtual twin technologies in healthcare.
The event marked an important milestone for ARTEMIs and reinforced ELPA’s commitment to ensuring that the patient voice remains at the centre of research, innovation and future healthcare solutions.
